UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 356

Sortiert nach

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Canadian Medical Association journal (CMAJ), 2010-11, Vol.182 (17), p.1864

2010

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for low bone mass in healthy 40-60 year old women: A systematic review of the literature

Osteoporosis international, 2009-01, Vol.20 (1), p.1-21

2009

Link zum Volltext

Verfügbarkeit prüfen

Trabecular bone score in kidney transplant recipients

Osteoporosis international, 2016-03, Vol.27 (3), p.1115-1121

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

The New England journal of medicine, 2001-05, Vol.344 (19), p.1434-1441

2001

Link zum Volltext

Verfügbarkeit prüfen

Rates and Properties of Type Ia Supernovae as a Function of Mass and Star Formation in Their Host Galaxies

The Astrophysical journal, 2006-09, Vol.648 (2), p.868-883

2006

Link zum Volltext

Verfügbarkeit prüfen

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

The journal of clinical endocrinology and metabolism, 2000-06, Vol.85 (6), p.2129-2134

2000

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures

Osteoporosis international, 2005-04, Vol.16 (4), p.403-410

2005

Link zum Volltext

Verfügbarkeit prüfen

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

Bone (New York, N.Y.), 2000-08, Vol.27 (2), p.311-318

2000

Link zum Volltext

Verfügbarkeit prüfen

Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial

Journal of thrombosis and haemostasis, 2007-08, Vol.5 (8), p.1600-1606

2007

Link zum Volltext

Verfügbarkeit prüfen

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Endocrine reviews, 2005-08, Vol.26 (5), p.688-703

2005

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues

Journal of bone and mineral research, 2000-06, Vol.15 (6), p.1033-1044

2000

Link zum Volltext

Verfügbarkeit prüfen

Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis

Canadian Medical Association journal (CMAJ), 2006-07, Vol.175 (1), p.48

2006

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone Versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis

The journal of clinical endocrinology and metabolism, 1997-02, Vol.82 (2), p.620-628

1997

Link zum Volltext

Verfügbarkeit prüfen

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

Journal of allergy and clinical immunology, 1995-08, Vol.96 (2), p.157-166

1995

Link zum Volltext

Verfügbarkeit prüfen

Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation

Bone (New York, N.Y.), 2000-03, Vol.26 (3), p.221-225

2000

Link zum Volltext

Verfügbarkeit prüfen

Management of corticosteroid-induced osteoporosis

Seminars in arthritis and rheumatism, 2000-02, Vol.29 (4), p.228-251

2000

Link zum Volltext

Verfügbarkeit prüfen

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

The Journal of clinical investigation, 1993-03, Vol.91 (3), p.1138-1148

1993

Link zum Volltext

Verfügbarkeit prüfen

Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats

Bone (New York, N.Y.), 1995-03, Vol.16 (3), p.357-365

1995

Link zum Volltext

Verfügbarkeit prüfen

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces

Bone (New York, N.Y.), 1993, Vol.14 (3), p.523-527

1993

Link zum Volltext

Verfügbarkeit prüfen

Use of FTIR Spectroscopic Imaging to Identify Parameters Associated With Fragility Fracture

Journal of bone and mineral research, 2009-09, Vol.24 (9), p.1565-1571

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the biochemical responses to human parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans

The journal of clinical endocrinology and metabolism, 1999-08, Vol.84 (8), p.2739-2743

1999

Link zum Volltext

Verfügbarkeit prüfen

Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate

The journal of clinical endocrinology and metabolism, 2008-10, Vol.93 (10), p.3785-3793

2008

Link zum Volltext

Verfügbarkeit prüfen

Appropriate X-ray ordering depends on physician characteristics: Canadian Quality Circle (CQC) national project

Bone (New York, N.Y.), 2009-06, Vol.44, p.S366-S367

2009

Link zum Volltext

Verfügbarkeit prüfen

The impact of physician characteristics on bone mineral density ordering: Canadian Quality Circle (CQC) national project

Bone (New York, N.Y.), 2009-06, Vol.44, p.S377-S377

2009

Link zum Volltext

Verfügbarkeit prüfen

A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture

Menopause (New York, N.Y.), 2015-08, Vol.22 (8), p.806

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 356

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(292)
Mit Volltextzugriff
(300)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(355)
Japanisch
(27)
Deutsch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

Risk factors for low bone mass in healthy 40-60 year old women: A systematic review of the literature

Trabecular bone score in kidney transplant recipients

Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis

Rates and Properties of Type Ia Supernovae as a Function of Mass and Star Formation in Their Host Galaxies

Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate

Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures

Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis

Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial

Parathyroid Hormone and Teriparatide for the Treatment of Osteoporosis: A Review of the Evidence and Suggested Guidelines for Its Use

Nuclear Localization of the Type 1 PTH/PTHrP Receptor in Rat Tissues

Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone Versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis

Bone mineral density and the risk of fracture in patients receiving long-term inhaled steroid therapy for asthma

Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation

Management of corticosteroid-induced osteoporosis

An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis

Parathyroid hormone restores bone mass and enhances osteoblast insulin-like growth factor I gene expression in ovariectomized rats

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: Evidence for de novo bone formation on quiescent cancellous surfaces

Use of FTIR Spectroscopic Imaging to Identify Parameters Associated With Fragility Fracture

Comparison of the biochemical responses to human parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans

Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate

Appropriate X-ray ordering depends on physician characteristics: Canadian Quality Circle (CQC) national project

The impact of physician characteristics on bone mineral density ordering: Canadian Quality Circle (CQC) national project

A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: effects on bone density and fracture

Suchergebnisse filtern